Dr. Bill, Hope you're right with your trial result estimates. I can't believe we're back below $10. I'm very tempted to buy more at this level, but I'm already overweight with RPRX. At around a $120M cap, this is an outstanding value and very safe IMO. I enjoy your 'grapevine' posts, so keep them up.